126 related articles for article (PubMed ID: 37452695)
1. A Single-Molecule Bioelectronic Portable Array for Early Diagnosis of Pancreatic Cancer Precursors.
Genco E; Modena F; Sarcina L; Björkström K; Brunetti C; Caironi M; Caputo M; Demartis VM; Di Franco C; Frusconi G; Haeberle L; Larizza P; Mancini MT; Österbacka R; Reeves W; Scamarcio G; Scandurra C; Wheeler M; Cantatore E; Esposito I; Macchia E; Torricelli F; Viola FA; Torsi L
Adv Mater; 2023 Oct; 35(42):e2304102. PubMed ID: 37452695
[TBL] [Abstract][Full Text] [Related]
2. A large-area organic transistor with 3D-printed sensing gate for noninvasive single-molecule detection of pancreatic mucinous cyst markers.
Sarcina L; Viola F; Modena F; Picca RA; Bollella P; Di Franco C; Cioffi N; Caironi M; Österbacka R; Esposito I; Scamarcio G; Torsi L; Torricelli F; Macchia E
Anal Bioanal Chem; 2022 Jul; 414(18):5657-5669. PubMed ID: 35410389
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Clinical Samples of Pancreatic Cyst's Lesions with A Multi-Analyte Bioelectronic Simot Array Benchmarked Against Ultrasensitive Chemiluminescent Immunoassay.
Scandurra C; Björkström K; Caputo M; Sarcina L; Genco E; Modena F; Viola FA; Brunetti C; Kovács-Vajna ZM; Franco CD; Haeberle L; Larizza P; Mancini MT; Österbacka R; Reeves W; Scamarcio G; Wheeler M; Caironi M; Cantatore E; Torricelli F; Esposito I; Macchia E; Torsi L
Adv Sci (Weinh); 2024 Jan; ():e2308141. PubMed ID: 38234100
[TBL] [Abstract][Full Text] [Related]
4. Value of adding GNAS testing to pancreatic cyst fluid KRAS and carcinoembryonic antigen analysis for the diagnosis of intraductal papillary mucinous neoplasms.
Kadayifci A; Atar M; Wang JL; Forcione DG; Casey BW; Pitman MB; Brugge WR
Dig Endosc; 2017 Jan; 29(1):111-117. PubMed ID: 27514845
[TBL] [Abstract][Full Text] [Related]
5. Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts.
Jones M; Zheng Z; Wang J; Dudley J; Albanese E; Kadayifci A; Dias-Santagata D; Le L; Brugge WR; Fernandez-del Castillo C; Mino-Kenudson M; Iafrate AJ; Pitman MB
Gastrointest Endosc; 2016 Jan; 83(1):140-8. PubMed ID: 26253016
[TBL] [Abstract][Full Text] [Related]
6. Clinical Impact of KRAS and GNAS Analysis Added to CEA and Cytology in Pancreatic Cystic Fluid Obtained by EUS-FNA.
Faias S; Duarte M; Albuquerque C; da Silva JP; Fonseca R; Roque R; Dias Pereira A; Chaves P; Cravo M
Dig Dis Sci; 2018 Sep; 63(9):2351-2361. PubMed ID: 29796909
[TBL] [Abstract][Full Text] [Related]
7. Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts.
Singhi AD; Nikiforova MN; Fasanella KE; McGrath KM; Pai RK; Ohori NP; Bartholow TL; Brand RE; Chennat JS; Lu X; Papachristou GI; Slivka A; Zeh HJ; Zureikat AH; Lee KK; Tsung A; Mantha GS; Khalid A
Clin Cancer Res; 2014 Aug; 20(16):4381-9. PubMed ID: 24938521
[TBL] [Abstract][Full Text] [Related]
8. Lower cyst fluid carcinoembryonic antigen cutoff is helpful in the differential diagnosis of mucinous versus non-mucinous pancreatic cysts.
Sharma RK; Bush N; Rana SS; Srinivasan R; Nada R; Gupta R; Rana S; Singh T
Indian J Gastroenterol; 2022 Aug; 41(4):397-404. PubMed ID: 36057043
[TBL] [Abstract][Full Text] [Related]
9. KRAS/GNAS-testing by highly sensitive deep targeted next generation sequencing improves the endoscopic ultrasound-guided workup of suspected mucinous neoplasms of the pancreas.
Schmitz D; Kazdal D; Allgäuer M; Trunk M; Vornhusen S; Nahm AM; Doll M; Weingärtner S; Endris V; Penzel R; Kirchner M; Brandt R; Neumann O; Sültmann H; Budczies J; Kienle P; Magdeburg R; Hetjens S; Schirmacher P; Bergmann F; Rudi J; Stenzinger A; Volckmar AL
Genes Chromosomes Cancer; 2021 Jul; 60(7):489-497. PubMed ID: 33686791
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study.
Khalid A; Zahid M; Finkelstein SD; LeBlanc JK; Kaushik N; Ahmad N; Brugge WR; Edmundowicz SA; Hawes RH; McGrath KM
Gastrointest Endosc; 2009 May; 69(6):1095-102. PubMed ID: 19152896
[TBL] [Abstract][Full Text] [Related]
11. A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts.
Sreenarasimhaiah J; Lara LF; Jazrawi SF; Barnett CC; Tang SJ
JOP; 2009 Mar; 10(2):163-8. PubMed ID: 19287110
[TBL] [Abstract][Full Text] [Related]
12. Addition of analysis of KRAS mutation or immunohistochemistry with MUC1 and carcinoembryonic antigen improves the diagnostic performance of fine needle aspiration cytology for the diagnosis of pancreatic carcinoma.
Gómez-Peñaloza C; Serrano-Arévalo ML; Villegas-González LF; Flores-Hernández L; Lino-Silva LS; Ruiz-García EB; Diaz-Chávez J
Cytopathology; 2019 Sep; 30(5):485-491. PubMed ID: 30929285
[TBL] [Abstract][Full Text] [Related]
13. Detection of KRAS Mutations in Circulating Tumor DNA by Digital PCR in Early Stages of Pancreatic Cancer.
Brychta N; Krahn T; von Ahsen O
Clin Chem; 2016 Nov; 62(11):1482-1491. PubMed ID: 27591291
[TBL] [Abstract][Full Text] [Related]
14. Mutational Mosaics of Cell-Free DNA from Pancreatic Cyst Fluids.
Paziewska A; Polkowski M; Goryca K; Karczmarski J; Wiechowska-Kozlowska A; Dabrowska M; Mikula M; Ostrowski J
Dig Dis Sci; 2020 Aug; 65(8):2294-2301. PubMed ID: 31925676
[TBL] [Abstract][Full Text] [Related]
15. Comparison of carcinoembryonic antigen and molecular analysis in pancreatic cyst fluid.
Sawhney MS; Devarajan S; O'Farrel P; Cury MS; Kundu R; Vollmer CM; Brown A; Chuttani R; Pleskow DK
Gastrointest Endosc; 2009 May; 69(6):1106-10. PubMed ID: 19249035
[TBL] [Abstract][Full Text] [Related]
16. Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia.
Singhi AD; McGrath K; Brand RE; Khalid A; Zeh HJ; Chennat JS; Fasanella KE; Papachristou GI; Slivka A; Bartlett DL; Dasyam AK; Hogg M; Lee KK; Marsh JW; Monaco SE; Ohori NP; Pingpank JF; Tsung A; Zureikat AH; Wald AI; Nikiforova MN
Gut; 2018 Dec; 67(12):2131-2141. PubMed ID: 28970292
[TBL] [Abstract][Full Text] [Related]
17. "Simple Mucinous Cyst" of the Pancreas: A Clinicopathologic Analysis of 39 Examples of a Diagnostically Challenging Entity Distinct From Intraductal Papillary Mucinous Neoplasms and Mucinous Cystic Neoplasms.
Krasinskas AM; Oakley GJ; Bagci P; Jang KT; Kuan SF; Reid MD; Erbarut I; Adsay V
Am J Surg Pathol; 2017 Jan; 41(1):121-127. PubMed ID: 27740966
[TBL] [Abstract][Full Text] [Related]
18. Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts.
Nikiforova MN; Khalid A; Fasanella KE; McGrath KM; Brand RE; Chennat JS; Slivka A; Zeh HJ; Zureikat AH; Krasinskas AM; Ohori NP; Schoedel KE; Navina S; Mantha GS; Pai RK; Singhi AD
Mod Pathol; 2013 Nov; 26(11):1478-87. PubMed ID: 23743931
[TBL] [Abstract][Full Text] [Related]
19. Organic Field-Effect Transistor Platform for Label-Free, Single-Molecule Detection of Genomic Biomarkers.
Macchia E; Manoli K; Di Franco C; Picca RA; Österbacka R; Palazzo G; Torricelli F; Scamarcio G; Torsi L
ACS Sens; 2020 Jun; 5(6):1822-1830. PubMed ID: 32495625
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of EUS-acquired pancreatic cyst fluid for KRAS and GNAS mutations for diagnosis of intraductal papillary mucinous neoplasia and mucinous cystic lesions: a systematic review and meta-analysis.
McCarty TR; Paleti S; Rustagi T
Gastrointest Endosc; 2021 May; 93(5):1019-1033.e5. PubMed ID: 33359054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
